Factory Provide Strontium Ranelate CAS 135459-87-9 Distrontium Renelate

Introduction

Product Name : Strontium Ranelate;Distrontium Renelate

Other name:;StrontiuM ranelate (Protelos);2,2'-((5-Carboxy-4-(carboxyMethyl)-3-cyanothiophen-2-yl)azanediyl)diacetic acid, distrontiuM salt

CAS No.: 135459-87-9

MF: C12H12N2O8SSr

MW:431.91

Appearance: White Powder

Melting Point :>310°C (dec.)

Storage :Keep in dark place,Sealed in dry,Room Temperature

Strontium ranelate is a drug for the treatment of osteoporosis, which is white to yellowish powder or crystalline powder, odorless, slightly soluble in water, almost insoluble in ethanol. Strontium ranelate has dual pharmacological effects of inhibiting bone resorption and promoting bone formation. On the one hand, in osteoblast-enriched cells, it can increase the synthesis of collagen and non-collagen, and promote osteoblast-mediated bone formation by enhancing the proliferation of preosteoblasts. On the other hand, by reducing the differentiation and resorption activity of osteoclasts, bone resorption is reduced, and bone regeneration is rebalanced, which is beneficial to bone formation.

Appplication

It is mainly used to treat and prevent osteoporosis in postmenopausal women and significantly reduce the risk of vertebral and hip fractures.